全球泛自閉症障礙診斷市場規模、佔有率、趨勢和成長分析報告（2026-2034）

泛自閉症障礙診斷市場預計將從 2025 年的 389.6 億美元成長到 2034 年的 597.1 億美元，2026 年至 2034 年的複合年成長率為 4.86%。

由於人們對發展障礙的認知不斷提高以及早期篩檢工作的推進，全球泛自閉症障礙診斷市場正穩步擴張。泛自閉症障礙（ASD）在全球盛行率的上升是推動先進診斷工具需求的主要動力。早期診斷在提高介入措施的有效性方面發揮著至關重要的作用，從而進一步促進了市場成長。

成長要素包括神經影像技術的進步、基因檢測技術的改進以及標準化行為評估工具的廣泛應用。政府和非營利組織對早期兒童篩檢計畫的推廣也促進了診斷率的提高。此外，兒童醫療保健服務的可近性提高也對市場產生了積極影響。

未來幾年，人工智慧診斷平台與數位行為評估工具的整合有望提升診斷的準確性和效率。自閉症譜系障礙（ASD）相關遺傳和神經因素研究的進展將推動技術創新。新興地區醫療基礎設施的擴建有望為參與企業創造新的成長機會。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球泛自閉症障礙診斷市場：依疾病分類

• 市場分析、洞察與預測
• 自閉症譜系障礙
• 亞斯伯格症候群
• 廣泛性發展障礙（PDD）
• 其他

第5章 全球泛自閉症障礙診斷市場：依服務類型分類

• 市場分析、洞察與預測
• 行為療法
• 早期療育
• 製藥
• 其他

第6章 全球泛自閉症障礙診斷市場：依機構分類

• 市場分析、洞察與預測
• 醫院
• 教育諮商中心
• 其他

第7章 全球泛自閉症障礙診斷市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Jazz Pharmaceuticals
  • Axial Therapeutics
  • Dfusion Inc
  • Cognoa Inc
  • Johnson & Johnson
  • Novartis AG
  • Abbvie Inc
  • Curemark LLC
  • EarliTec Diagnostics Inc
  • Bristol Myers Squibb Co

The Autism Spectrum Disorder Diagnostics Market size is expected to reach USD 59.71 Billion in 2034 from USD 38.96 Billion (2025) growing at a CAGR of 4.86% during 2026-2034.

The Global Autism Spectrum Disorder Diagnostics Market is expanding steadily due to increasing awareness and early screening initiatives for developmental disorders. Rising prevalence of autism spectrum disorder (ASD) globally has significantly driven demand for advanced diagnostic tools. Early diagnosis plays a critical role in improving intervention outcomes, further strengthening market growth.

Growth drivers include advancements in neuroimaging techniques, genetic testing technologies, and standardized behavioral assessment tools. Government and non-profit initiatives promoting early childhood screening programs are contributing to higher diagnosis rates. Additionally, improved access to pediatric healthcare services is positively impacting the market.

In the coming years, integration of AI-based diagnostic platforms and digital behavioral assessment tools is expected to enhance accuracy and efficiency. Growing research into genetic and neurological factors associated with ASD will further support innovation. Expanding healthcare infrastructure in emerging regions will create additional growth opportunities for market participants.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Disease

• Autistic Disorder
• Asperger Syndrome
• Pervasive Development Disorder (PDD)
• Other

By Service

• Behavioural Approaches
• Early Intervention
• Medication
• Other

By Location

• Hospitals
• Education Counsellor Center
• Others

COMPANIES PROFILED

• Jazz Pharmaceuticals, Axial therapeutics, dfusion inc, Cognoa Inc, Johnson Johnson, Novartis AG, Abbvie Inc, Curemark LLC, EarliTec Diagnostics Inc, Bristol Myers Squibb Co
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL AUTISM SPECTRUM DISORDER DIAGNOSTICS MARKET: BY DISEASE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Disease
• 4.2. Autistic Disorder Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Asperger Syndrome Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Pervasive Development Disorder (PDD) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL AUTISM SPECTRUM DISORDER DIAGNOSTICS MARKET: BY SERVICE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Service
• 5.2. Behavioural Approaches Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Early Intervention Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Medication Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL AUTISM SPECTRUM DISORDER DIAGNOSTICS MARKET: BY LOCATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Location
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Education Counsellor Center Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL AUTISM SPECTRUM DISORDER DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Disease
  • 7.2.2 By Service
  • 7.2.3 By Location
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Disease
  • 7.3.2 By Service
  • 7.3.3 By Location
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Disease
  • 7.4.2 By Service
  • 7.4.3 By Location
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Disease
  • 7.5.2 By Service
  • 7.5.3 By Location
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Disease
  • 7.6.2 By Service
  • 7.6.3 By Location
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL AUTISM SPECTRUM DISORDER DIAGNOSTICS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Jazz Pharmaceuticals
  • 9.2.2 Axial Therapeutics
  • 9.2.3 Dfusion Inc
  • 9.2.4 Cognoa Inc
  • 9.2.5 Johnson & Johnson
  • 9.2.6 Novartis AG
  • 9.2.7 Abbvie Inc
  • 9.2.8 Curemark LLC
  • 9.2.9 EarliTec Diagnostics Inc
  • 9.2.10 Bristol Myers Squibb Co